Biogen Inc

FDA advisors endorse Alzheimer’s treatment Leqembi paving way for full approval this summer

FDA advisors endorse Alzheimer’s treatment Leqembi paving way for full approval this summer

James Brando June 9, 2023

The Alzheimer’s drug Leqembi is seen in this undated handout image obtained by Reuters...

Alzheimer’s treatment Leqembi could cost Medicare up to $5 billion per year, study estimates

Alzheimer’s treatment Leqembi could cost Medicare up to $5 billion per year, study estimates

James Brando May 12, 2023

The Alzheimer’s drug LEQEMBI is seen in this undated handout image obtained by Reuters...

Bipartisan attorneys general call on Medicare to cover Alzheimer’s treatments

Bipartisan attorneys general call on Medicare to cover Alzheimer’s treatments

James Brando May 1, 2023

Democratic and Republican attorneys general in nearly half of U.S. states are calling on...

Here are Monday’s biggest analyst calls: Apple, JPMorgan, Zillow, General Motors, Exxon, Tesla & more

Here are Monday’s biggest analyst calls: Apple, JPMorgan, Zillow, General Motors, Exxon, Tesla & more

James Brando May 1, 2023

Here are Monday’s biggest calls on Wall Street: Morgan Stanley upgrades General Motors to...

Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease

Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease

James Brando April 30, 2023

Juanmonino | E+ | Getty Images Seniors with early Alzheimer’s disease will face major...